Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Aug 03, 2026
Coherent Corp. (COHR): Can the Stock Reclaim the $400 Level?

Coherent Corp. (COHR): Can the Stock Reclaim the $400 Level?

Key Takeaways

  • Price Target in Focus: COHR currently trades near $263, making the $400 level a roughly 52% upside target that aligns with price objectives from BofA, Craig-Hallum, and the broader analyst consensus of approximately $391-$395.
  • AI Demand Engine: A $2 billion strategic investment and multiyear supply agreement with NVDA (NVIDIA) anchors Coherent's role in next-generation AI data center optics, with 800G and 1.6T transceiver volumes accelerating.
  • Margin Expansion Story: The transition to 6-inch indium phosphide wafers promises significant cost advantages, with management targeting gross margins above 42% over the long term.
  • Key Risks: Elevated valuation multiples, a 29% one-month decline, Bain Capital's ongoing share sales, and concentrated hyperscaler demand represent meaningful headwinds.
  • Technical Landscape: The $300 level represents a near-term psychological resistance barrier, while $350-$370 marks a prior consolidation zone that must be cleared before $400 comes into view.
  • Bottom Line: $400 is achievable but likely requires successful execution on multiple product ramps through late 2026 and into 2027, along with sustained AI capital expenditure growth.

Why the $400 Level Draws Attention

The $400 price target has emerged as a widely cited milestone across Wall Street. Bank of America raised its target to $400 in May, citing Coherent's 20-30% share of the global optical transceiver market. Craig-Hallum similarly boosted its target to $400. Meanwhile, more bullish firms like Raymond James and J.P. Morgan have set targets at $435, while CMB International initiated coverage with a Street-high $465 objective.

The average analyst price target stands at roughly $391, with a median near $402, according to MarketWatch. This clustering around the $400 mark makes it a natural focal point. For many institutional investors, $400 also represents a psychologically significant round number and a threshold that would confirm the stock's ability to recover from its recent correction. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Drivers That Could Fuel Further Gains

Coherent's strongest catalyst is the relentless expansion of AI data center infrastructure. The company's Datacenter & Communications segment grew more than 40% year-over-year in the most recent quarter, now representing roughly 75% of total revenue. Third-quarter fiscal 2026 revenue reached $1.81 billion, beating consensus estimates, while non-GAAP earnings per share of $1.41 marked a 55% increase from the prior year.

The NVIDIA partnership, announced earlier this year, involves a $2 billion equity investment and multibillion-dollar purchase commitments for advanced laser and optical components. This arrangement not only validates Coherent's technology but also provides multiyear revenue visibility, with orders now extending into calendar 2028.

Beyond transceivers, Coherent is poised to benefit from several emerging product cycles. Co-packaged optics (CPO) revenue is expected to begin ramping in the second half of calendar 2026, multi-rail systems for connecting AI data centers across greater distances should start contributing in early 2027, and thermal management products for data centers are slated for the second half of 2027. Each of these represents an incremental growth vector beyond the core transceiver business.

Hurdles Standing in the Way

Despite the bullish narrative, several factors complicate the path to $400. The stock's 29% decline over the past month highlights the elevated volatility that accompanies high-growth, high-valuation names. With a forward price-to-earnings (P/E) ratio near 35 and a trailing P/E above 100, the stock commands a significant premium that leaves little room for execution missteps.

Bain Capital's ongoing selldown of its Coherent stake, most recently through a secondary offering led by Goldman Sachs, has added supply pressure to the stock. While this selling reflects portfolio management rather than a fundamental judgment on the business, it has nonetheless weighed on sentiment. From what I see, the competitive landscape adds another layer of complexity here.

Morgan Stanley remains an outlier with an Equal-Weight rating and a $330 price target, expressing caution about how effectively Coherent can convert expanding market opportunity into sustained shareholder returns. Meanwhile, BofA maintained a Neutral rating even as it raised its target to $400, suggesting that much of the good news may already be priced in.

Competitive risks also merit attention. Low-cost Asian optical component manufacturers continue to expand their capabilities, and the concentrated nature of hyperscaler demand means that any slowdown in AI capital expenditure could disproportionately affect Coherent's revenue trajectory.

Technical Levels Worth Monitoring

From a technical perspective, Coherent's stock faces several important zones on the way to $400. The $300 level represents the first major psychological hurdle and coincides with a round-number resistance that has historically attracted selling pressure. Beyond that, the $350-$370 zone marks a prior area of consolidation where the stock traded extensively before its recent selloff. A sustained breakout above $370 would signal that buyers have absorbed overhead supply and could open the door for a push toward $400 and eventually the 52-week high of $440.

On the downside, the $250 area has emerged as near-term support, with the 52-week low at approximately $84 representing a floor established during earlier market turbulence. The wide range between these extremes underscores the stock's high-beta nature and the importance of risk management for positions built around the $400 target. I also reviewed recent patterns with Tickeron’s AI Pattern Search Engine for additional context.

AI Daily Buy/Sell Signals

Navigating a volatile stock like Coherent requires timely and data-driven decision-making. In my own process, I use Tickeron’s AI Daily Buy/Sell Signals to monitor thousands of stocks and ETFs, generating actionable Buy, Sell, or Hold signals based on evolving market conditions, technical patterns, and AI-driven analysis. These tools help me identify emerging opportunities, reassess positions, and stay ahead of shifting trends without manually tracking every chart. For those watching whether COHR can sustain momentum toward the $400 level, they offer an efficient way to track changes in real time.

Final Assessment

The question of whether Coherent can reach $400 is not merely about a number; it is about whether the AI infrastructure buildout has enough runway to support another leg higher in optical component demand. The fundamental case is compelling: Coherent holds a leading position in the global transceiver market, has secured a landmark partnership with NVIDIA, and is ramping multiple new product lines that could drive revenue growth well beyond current levels. Analyst consensus firmly supports upside, with the average target already hovering near $400.

However, the stock's recent correction, premium valuation, and the presence of a large selling shareholder introduce substantial uncertainty. Reaching $400 likely requires at least one or two quarters of strong execution, evidence that CPO and multi-rail revenues are scaling as projected, and a broader market environment that continues to reward AI-exposed growth stocks. The upcoming fiscal fourth-quarter earnings report on August 12 may serve as a near-term catalyst that either strengthens or weakens the path toward this widely watched target. Investors should monitor revenue growth trends, gross margin progression, and any updates to the NVIDIA partnership timeline as the clearest indicators of whether $400 is a realistic destination or an aspirational ceiling.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: COHR

COHR in +15.51% Uptrend, rising for three consecutive days on August 07, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where COHR advanced for three days, in of 339 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 03, 2026. You may want to consider a long position or call options on COHR as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for COHR just turned positive on August 04, 2026. Looking at past instances where COHR's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for COHR moved out of overbought territory on August 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 49 similar instances where the indicator moved out of overbought territory. In of the 49 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

COHR moved below its 50-day moving average on August 10, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for COHR crossed bearishly below the 50-day moving average on July 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

COHR broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for COHR entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. COHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.515) is normal, around the industry mean (4.470). P/E Ratio (169.352) is within average values for comparable stocks, (89.105). COHR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.155). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (9.709) is also within normal values, averaging (30.509).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Industry description

This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.

Market Cap

The average market capitalization across the Electronic Equipment/Instruments Industry is 9.25B. The market cap for tickers in the group ranges from 27.54K to 122.53B. KYCCF holds the highest valuation in this group at 122.53B. The lowest valued company is CSEC at 27.54K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Equipment/Instruments Industry was -1%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 9%. MVIS experienced the highest price growth at 46%, while FCUV experienced the biggest fall at -47%.

Volume

The average weekly volume growth across all stocks in the Electronic Equipment/Instruments Industry was -27%. For the same stocks of the Industry, the average monthly volume growth was -11% and the average quarterly volume growth was -63%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 55
Price Growth Rating: 52
SMR Rating: 79
Profit Risk Rating: 78
Seasonality Score: -14 (-100 ... +100)
View a ticker or compare two or three
COHR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a maker of laser diodes and other laser equipment

Industry ElectronicEquipmentInstruments

Profile
Details
Industry
Electronic Equipment Or Instruments
Address
375 Saxonburg Boulevard
Phone
+1 724 352-4455
Employees
26622
Web
https://www.ii-vi.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Coherent Corp. (COHR): Can the Stock Reclaim the $400 Level?